- The Superiority of 68Ga‑FAPI‑04 over 18F‑FDG in a Case of Gallbladder Cancer
-
Guo C, Peng D, Liu Y, Chen L, Huang Z
- KMID: 2534413
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):252-255.
- doi: 10.1007/s13139-022-00763-5
A 56-year-old man presented with vague upper abdominal pain for more than 4 months. His abdominal ultrasound and MRI showed thickening of the neck and base of the gallbladder and nodule... -
- CITED
-
- Close
- SHARE
-
- Close
- Extensive Venous Tumor Thrombi in a Case of Malignant Melanoma: Role of 18F FDG PET/CT
-
Yaghoobi N, Hedayati R, Malek H, Maghsudi M
- KMID: 2534414
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):256-258.
- doi: 10.1007/s13139-022-00757-3
The 18F-FDG PET/CT imaging is a non-invasive modality for diagnosis and staging of metastatic melanoma. Venous thromboembolism (VTE) is a common complication of cancers, which needs anticoagulant therapy. Tumor thrombosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging Findings of 18F‑Choline and 18F‑DOPA PET/MRI in a Case of Glioblastoma Multiforme Pseudoprogression: Correlation with Clinical Outcome
-
Filippi L, Spanu A, Bagni O, Schillaci O, Palumbo B
- KMID: 2534412
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):245-251.
- doi: 10.1007/s13139-022-00758-2
We describe the case of 74-year-old-male, previously treated with fronto-parietal craniotomy due to primary glioblastoma multiforme (GBM), followed by concurrent radiation therapy (RT) and temozolomide (TMZ) chemotherapy. Magnetic resonance imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Role of 18F‑DOPA PET/CT and 131I‑MIBG Scintigraphy in Neuroblastoma and Application of Curie and SIOPEN Scoring Systems in 18F‑DOPA PET/CT
-
Hemrom A, Arora G, Damle N, Bal C
- KMID: 2534411
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):236-244.
- doi: 10.1007/s13139-022-00762-6
Purpose Neuroblastoma (NB) is childhood’s most common extracranial solid malignancy. We have compared two imaging modalities, 131I-MIBG and 18F-DOPA PET/CT, to evaluate NB. Also, feasibility of the application of standardised... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes and Factors Associated with Completion of Radium‑223 Therapy
-
Liu R, Juwara L, Ferrario C, Probst S
- KMID: 2534410
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):228-235.
- doi: 10.1007/s13139-022-00760-8
Purpose Radium-223 has been demonstrated in clinical trials to improve survival in castration-resistant prostate cancer (CRPC) patients with bone metastases. However, its performance in routine use remains to be fully... -
- CITED
-
- Close
- SHARE
-
- Close
- 68Ga‑DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel‑Lindau Syndrome
-
Patel M, Jha A, Antic T, Nielsen S, Churpek J, Ling A, Pacak K
- KMID: 2534415
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):259-562.
- doi: 10.1007/s13139-022-00761-7
Although rare, a metastatic renal cell carcinoma could present with 68Ga-DOTATATE avidity. A 66-year-old man with von Hippel-Lindau syndrome (VHL) presented with 68Ga-DOTATATE uptake in the pancreatic head, splenic hilar... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of the Highest Regional Bone Scan Index in Patients with Metastatic Castration–Resistant Prostate Cancer
-
Nakai Y, Iemura Y, Miyasaka T, Hori S, Miyake M, Marugami N, Fujimoto K, Tanaka N
- KMID: 2534409
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):221-227.
- doi: 10.1007/s13139-022-00759-1
Purpose This study evaluated the clinical utility of the highest bone scan index (BSI), among other BSIs, for each bone metastatic site in patients with bone metastatic castration–resistant prostate cancer (bmCRPC). Methods... -
- CITED
-
- Close
- SHARE
-
- Close
